Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026)
Embecta's (EMBC) quarterly Depreciation & Amortization (CF) came in at $10.2 million in Q1 2026, up 13.33% year-on-year from $9.0 million in Q1 2025, and down 0.97% quarter-over-quarter from $10.3 million in Q4 2025.
Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Embecta has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $10.2 million for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $10.2 million, up 13.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.8 million (up 16.3% YoY), and the FY2025 annual result was $40.7 million, up 12.43% from the prior year.
- Depreciation & Amortization (CF) came in at $10.2 million for Q1 2026 at Embecta, down from $10.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $13.1 million in Q3 2025 to a low of $6.7 million in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $9.0 million (2024), against an average of $9.0 million.
- Across the five-year window, Depreciation & Amortization (CF) tumbled 34.31% in 2022 and surged 37.89% in 2025, its largest moves.
- Embecta's Depreciation & Amortization (CF) stood at $7.2 million in 2022, then gained by 22.22% to $8.8 million in 2023, then advanced by 6.82% to $9.4 million in 2024, then climbed by 9.57% to $10.3 million in 2025, then decreased by 0.97% to $10.2 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $10.2 million (Q1 2026), $10.3 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 10.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.20 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 8.80 Mn |
| Dec 31, 2023 | 8.80 Mn |